EIF4A3-regulated hsa_circ_0001445 can inhibit the progression of laryngeal squamous cell carcinoma via hsa-miR-432-5p-dependent up-regulation of RGMA expression
Laryngeal squamous cell carcinoma (LSCC) is a common malignant tumor in the head and neck, the 5-year relative survival rate of patients diagnosed with laryngeal cancer was estimated to be 61% from 2012 to 2018. An increasing number of studies have shown that circular RNAs (circRNAs) play a key role in the occurrence and development of cancer and may function as cancer biomarkers and new therapeutic targets. At present, the research on the relationship between circRNAs and LSCC is still in its infancy and needs further exploration. In this study, we found a circRNA (hsa_circ_0001445) associated with LSCC based on bioinformatics analysis. Quantitative real-time polymerase chain reaction (qRT-PCR) assay indicated that the expression of hsa_circ_0001445 was down-regulated in LSCC tissues and cell lines. Notably, the expression of hsa_circ_0001445 was negatively correlated with aggressive clinicopathological features and poor prognosis. Then, functional experiments found that overexpression of hsa_circ_0001445 inhibited the proliferation, migration and invasion of LSCC cells and tumor growth in vivo. Mechanistically, RNA immunoprecipitation (RIP), biotin-labeled probe pull-down, luciferase reporter assay and western blot experiments were employed and found that EIF4A3 reduced the expression of hsa_circ_0001445, and the direct binding of hsa_circ_0001445 to hsa-miR-432-5p attenuated the inhibitory effect of hsa-miR-432-5p on RGMA. In summary, our research suggests that hsa_circ_0001445 may be used as a potential prognostic biomarker and therapeutic target for LSCC.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
---|---|
Enthalten in: |
Cell cycle (Georgetown, Tex.) - 22(2023), 18 vom: 18. Sept., Seite 2038-2056 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yu, Miaomiao [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 24.11.2023 Date Revised 20.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/15384101.2023.2274670 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36394317X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM36394317X | ||
003 | DE-627 | ||
005 | 20240321235548.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/15384101.2023.2274670 |2 doi | |
028 | 5 | 2 | |a pubmed24n1338.xml |
035 | |a (DE-627)NLM36394317X | ||
035 | |a (NLM)37902305 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Yu, Miaomiao |e verfasserin |4 aut | |
245 | 1 | 0 | |a EIF4A3-regulated hsa_circ_0001445 can inhibit the progression of laryngeal squamous cell carcinoma via hsa-miR-432-5p-dependent up-regulation of RGMA expression |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.11.2023 | ||
500 | |a Date Revised 20.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Laryngeal squamous cell carcinoma (LSCC) is a common malignant tumor in the head and neck, the 5-year relative survival rate of patients diagnosed with laryngeal cancer was estimated to be 61% from 2012 to 2018. An increasing number of studies have shown that circular RNAs (circRNAs) play a key role in the occurrence and development of cancer and may function as cancer biomarkers and new therapeutic targets. At present, the research on the relationship between circRNAs and LSCC is still in its infancy and needs further exploration. In this study, we found a circRNA (hsa_circ_0001445) associated with LSCC based on bioinformatics analysis. Quantitative real-time polymerase chain reaction (qRT-PCR) assay indicated that the expression of hsa_circ_0001445 was down-regulated in LSCC tissues and cell lines. Notably, the expression of hsa_circ_0001445 was negatively correlated with aggressive clinicopathological features and poor prognosis. Then, functional experiments found that overexpression of hsa_circ_0001445 inhibited the proliferation, migration and invasion of LSCC cells and tumor growth in vivo. Mechanistically, RNA immunoprecipitation (RIP), biotin-labeled probe pull-down, luciferase reporter assay and western blot experiments were employed and found that EIF4A3 reduced the expression of hsa_circ_0001445, and the direct binding of hsa_circ_0001445 to hsa-miR-432-5p attenuated the inhibitory effect of hsa-miR-432-5p on RGMA. In summary, our research suggests that hsa_circ_0001445 may be used as a potential prognostic biomarker and therapeutic target for LSCC | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a EIF4A3 | |
650 | 4 | |a Laryngeal squamous cell carcinoma | |
650 | 4 | |a RGMA | |
650 | 4 | |a hsa-miR-432-5p | |
650 | 4 | |a hsa_circ_0001445 | |
650 | 7 | |a MIRN432 microRNA, human |2 NLM | |
650 | 7 | |a RNA, Circular |2 NLM | |
650 | 7 | |a MicroRNAs |2 NLM | |
650 | 7 | |a EIF4A3 protein, human |2 NLM | |
650 | 7 | |a EC 3.6.1.- |2 NLM | |
650 | 7 | |a Eukaryotic Initiation Factor-4A |2 NLM | |
650 | 7 | |a EC 2.7.7.- |2 NLM | |
650 | 7 | |a DEAD-box RNA Helicases |2 NLM | |
650 | 7 | |a EC 3.6.4.13 |2 NLM | |
700 | 1 | |a Cao, Huan |e verfasserin |4 aut | |
700 | 1 | |a Yang, Jianwang |e verfasserin |4 aut | |
700 | 1 | |a Liu, Tao |e verfasserin |4 aut | |
700 | 1 | |a Gao, Jiaxue |e verfasserin |4 aut | |
700 | 1 | |a Wang, Baoshan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cell cycle (Georgetown, Tex.) |d 2002 |g 22(2023), 18 vom: 18. Sept., Seite 2038-2056 |w (DE-627)NLM122165837 |x 1551-4005 |7 nnns |
773 | 1 | 8 | |g volume:22 |g year:2023 |g number:18 |g day:18 |g month:09 |g pages:2038-2056 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/15384101.2023.2274670 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 22 |j 2023 |e 18 |b 18 |c 09 |h 2038-2056 |